Loading...
XASXPME
Market cap16bUSD
Dec 20, Last price  
248.65AUD
1D
-0.63%
1Q
44.42%
Jan 2017
5,080.21%
Name

Pro Medicus Ltd

Chart & Performance

D1W1MN
XASX:PME chart
P/E
313.84
P/S
160.89
EPS
0.79
Div Yield, %
0.14%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
26.37%
Revenues
162m
+29.30%
10,276,00011,298,00012,539,0009,157,0009,940,00019,197,00013,969,00011,313,00011,154,00014,268,00017,490,00027,521,00031,597,00033,872,00050,105,00056,821,00067,884,00093,461,000124,900,000161,501,000
Net income
83m
+36.52%
5,493,0006,115,0007,052,0007,933,0005,683,0003,920,000503,0001,791,0005,131,0001,509,0003,217,0006,368,0009,321,0009,965,00019,125,00023,076,00030,850,00044,442,00060,648,00082,794,000
CFO
87m
+33.97%
4,461,0006,910,0005,805,0008,810,0005,477,0006,839,0006,250,0005,876,0003,813,0004,233,0004,183,00011,254,00014,829,00013,873,00024,658,00031,592,00039,020,00062,225,00064,772,99986,776,000
Dividend
Sep 04, 20240.22 AUD/sh
Earnings
Feb 13, 2025

Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
URL
https://www.promed.com.au/
IPO date
Oct 10, 2000
Employees
79
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
161,501
29.30%
124,900
33.64%
93,461
37.68%
Cost of revenue
72,466
44,313
33,860
Unusual Expense (Income)
NOPBT
89,035
80,587
59,601
NOPBT Margin
55.13%
64.52%
63.77%
Operating Taxes
33,704
25,478
18,637
Tax Rate
37.85%
31.62%
31.27%
NOPAT
55,331
55,109
40,964
Net income
82,794
36.52%
60,648
36.47%
44,442
44.06%
Dividends
(36,554)
(26,108)
(18,788)
Dividend yield
0.24%
0.38%
0.43%
Proceeds from repurchase of equity
(2,769)
(845)
509
BB yield
0.02%
0.01%
-0.01%
Debt
Debt current
553
1,425
604
Long-term debt
3,585
2,394
3,350
Deferred revenue
25,850
23,421
18,628
Other long-term liabilities
113
77
66
Net debt
(162,479)
(120,037)
(88,066)
Cash flow
Cash from operating activities
86,776
64,773
62,225
CAPEX
(6,693)
(6,446)
(9,023)
Cash from investing activities
(78,074)
(9,795)
(17,556)
Cash from financing activities
(39,841)
(27,527)
(23,314)
FCF
54,240
39,901
47,067
Balance
Cash
155,425
121,495
90,554
Long term investments
11,192
2,361
1,466
Excess cash
158,542
117,611
87,347
Stockholders' equity
187,728
138,776
101,732
Invested Capital
57,218
46,514
29,059
ROIC
106.68%
145.84%
118.82%
ROCE
39.85%
46.87%
47.87%
EV
Common stock shares outstanding
104,652
104,588
104,582
Price
143.26
118.25%
65.64
55.36%
42.25
-28.05%
Market cap
14,992,499
118.39%
6,865,133
55.37%
4,418,604
-28.06%
EV
14,830,020
6,745,096
4,330,538
EBITDA
97,545
88,513
66,917
EV/EBITDA
152.03
76.20
64.72
Interest
Interest/NOPBT